To Get Full Access :

NCE-1 Intelligence & Market Opportunity

Sofdra

Sofpironium
Antiperspirant
Metered Gel Topical

Sofdra is a topical anticholinergic gel for adults and children aged 9 and up suffering from underarm excessive sweating (primary axillary hyperhidrosis). Applied at bedtime, it helps reduce sweat production by blocking signals to sweat glands

Approval Date
18-Jun-24
NCE-1 Date
18-Jun-28
NCE Date
18-Jun-29
Commercial snapshot

Market performance & projections

Revenue ($M)
15
CAGR (%)
8.78%
Projected sales, 2026–2032 ($M)
Analyst projection, $M per year
2026
16
2027
18
2028
19
2029
21
2030
22
2031
23
2032
24
Molecule profile

Details & specifications

Molecule
Sofpironium
Innovator
BOTANIX SB INC
Dosage Form
Metered Gel Topical
Strength
EQ 12.45% base (EQ 72 mg base/actuation)
Therapeutic Category
Antiperspirant
Usage
To treat primary axillary hyperhidrosis
Good to know

Frequently asked questions

Ready to act on this opportunity?

Talk to Spring Bio Solution about sourcing, licensing, and filing support for this molecule.

Why Spring Bio Solution

Supported 1000+ clinical trials globally

Provides services across regulatory, legal & clinical research

Unmatched intelligence on batches, expiry, spacing, and historical data from innovators

Integrated CRO services as part of our offerings

Insights on global pricing for smarter clinical trial supply decisions

Global sourcing capability across US, EU, South Africa, Canada, Japan, Australia, New Zealand, Southeast Asia, and other key markets

Login With

For full access Sign-up / Sign-in using below Methods:

By continuing, you agree to our Terms & Conditions and Privacy Policy. You can review them anytime.

Are you sure want to logout from NCE Grid?